🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

MEDANTA vs NH: Stock Comparison

GLOBAL HEALTH vs NARAYANA HRUDAYALAYAUpdated 30 Oct 26, 9:33 AM ISTNSE & company filings

NARAYANA HRUDAYALAYA is the larger company by market capitalisation. GLOBAL HEALTH shows lower leverage and a higher net margin, while NARAYANA HRUDAYALAYA shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MEDANTA leads 3; NH leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MEDANTANH

Valuation lens

What price are you paying?

Market CapContext only
₹35,056 Cr
₹35,072 Cr
P/E RatioNH has the lower reading
62.54x
42.94x ✓
P/B RatioNH has the lower reading
8.78x
7.72x ✓
EPSNH has the higher reading
₹5.9
₹10.14 ✓
Book ValueContext only
₹148.18
₹222.13
Dividend YieldNH has the higher reading
0.04%
0.26% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NH is the larger company
₹35,072 Cr vs ₹35,056 Cr
P/E Ratio
NH has a lower P/E
42.94x vs 62.54x
P/B Ratio
NH has a lower P/B
7.72x vs 8.78x
EPS
NH has higher earnings per share
₹10.14 vs ₹5.9
Dividend Yield
NH has a higher dividend yield
0.26% vs 0.04%
Revenue Growth (TTM YoY)
NH has faster revenue growth
75.8% vs 24.5%
EPS Growth (TTM YoY)
MEDANTA has faster EPS growth
42% vs 13.5%
ROE
NH has a higher ROE
19.37% vs 13.91%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDANTANH
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricMEDANTANH
Live Price₹1,296.1₹1,716.1
Day Change-0.28%0.09%
Volume4,0527,450
52-Week High₹1,544₹2,093.3
52-Week Low₹956₹1,589
Distance from 52W High-16.06%-18.02%

Valuation

MetricMEDANTANH
Market Cap₹35,056 Cr₹35,072 Cr
P/E Ratio62.54x42.94x
P/B Ratio8.78x7.72x
EPS₹5.9₹10.14
Book Value₹148.18₹222.13
Dividend Yield0.04%0.26%

Growth

MetricMEDANTANH
Revenue Growth (TTM YoY)24.5%75.8%
EPS Growth (TTM YoY)42%13.5%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricMEDANTANH
ROE13.91%19.37%
ROCE11.9%14.13%
Net Margin12.62%10.2%
Operating Margin18.01%19.6%
Debt to Equity0.3x0.71x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricMEDANTANH
Promoter Holding33%58.27%▼ 5 pp
FII Holding9.91%▲ 0.45 pp9.01%▼ 0.39 pp
DII Holding17.01%▲ 0.12 pp10.68%▲ 1.62 pp
Public Holding39.97%▼ 0.59 pp16.42%▼ 1.23 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GLOBAL HEALTH and NARAYANA HRUDAYALAYA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.